Cerrone Gabriele M's Form 4/A amendment
AmendedTiziana Life Sciences Ltd (TLSA) · filed Aug 7, 2026
- Accession no.
- 0001213900-26-086697
- Filed
- Aug 7, 2026, 4:16 PM ET
- Trade date
- Jul 21, 2026
- Filing delay
- 17 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 23, 2026
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $41.9K. It was filed 17 days after the trade.
This amendment replaces 0001213900-26-080880 (filed Jul 23, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cerrone Gabriele MCIK 0001139306 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | COMMON STOCK | PPurchaseAcquired | +42,357 | $0.99 | +$41,933.43 | 44,814,587 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.